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The genetic mechanism of aspirin intolerant acute urticaria
(AIAU) is unknown. To demonstrate an association between
the 2 adrenergic receptor (ADRB2) polymorphism and the β
phenotype of AIAU, one hundred fourteen patients with
AIAU, 110 patients with aspirin intolerant chronic urticaria
(AICU), and 498 normal healthy controls (NC) based on a
Korean population were enrolled. The genotype of ADRB2 at
46 A> G was analyzed using a direct sequencing method. The
ADRB2 polymorphism at 46 A> G showed a significant
difference between AIAU and NC; the frequency of the major
genotype was significantly higher in the AIAU group (p =
0.017 in recessive model), while no differences were noted in
allele and genotype frequencies between AICU and NC. In
conclusion, the ADRB2 (46 A > G) gene polymorphism may
contribute to the development of the phenotype of AIAU.
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Aspirin intolerant acute urticaria (AIAU) presents
with the immediate onset of urticaria after aspirin
ingestion, which often resolves within 1 - 2 weeks.
1
Aspirin ingestion could aggravate chronic urticaria,
and this condition is defined as aspirin intolerant
chronic urticaria (AICU).
2 The prevalence of aspirin
intolerant urticaria is approximately 0.3% of the
normal population.
3 It is generally agreed that
aspirin triggers or aggravates chronic urticaria in
20% to 40% of patients.
4
The beta 2-adrenergic receptor having a potential
anti-inflammatory action of stabilizing mast cell
degranulation and releasing inflammatory
mediators
5 has been postulated to be involved in
the pathogenic mechanism of urticaria. In this
study, we analyzed ADRB2 polymorphisms in two
phenotypes of aspirin-induced urticaria, AIAU
and AICU, which were also compared with those
of normal healthy controls (NC) in the Korean
population.
One hundred fourteen patients with AIAU, 110
patients with AICU, and 498 normal healthy
controls (NC) were enrolled from the Department
of Allergy and Rheumatology, in Ajou University
Hospital, Suwon, Korea. AIAU was defined as a
condition in which patients suffer acute urticaria
when they are exposed to aspirin as confirmed by
an aspirin (Rhonal , KunWha Pharmaceutical Co.,
Seoul, Korea) oral provocation test as described in
a previous study.
6 The AICU phenotype was
defined presenting with daily or near-daily
spontaneous urticaria for a duration longer than
6 weeks and showing positive results (appearance
of urticaria within 4 hr without any changes of
FEV1) in an aspirin oral provocation test. Because
there has been abundant evidence to suggest an
association between the ADRB2 polymorphism at
46A > G and 79C > G with asthma related
phenotypes,
7,8 we excluded the patients with both
AIU and AIA to better analyze any associations
between the ADRB2 polymorphism and aspirin
intolerant urticaria in this study. All subjects
provided informed consent, and the protocol was
approved by the ethics committee of Ajou
University Hospital, Suwon, Korea. Atopy was
determined by a positive skin test to at least one
common aeroallergen including Dermatophagoides
pteronyssinus, Dermatophagoides farinae, cats, dogs,
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cockroaches, tree pollen mixture, grass pollen
mixture, mugwort, ragweed, Hop Japanese,
Aspergillus, Alternaria (Bencard, Bradford, U.K.).
Genomic DNA for the all subjects in the study
was extracted using the PUREGENE DNA
purification kit (Gentra systems Inc., MN, USA)
according to the manufacturer's instructions. Since
the minor allele frequency at 79 C > G polymor-
phism was very low in this cohort, we analyzed
only 46A > G exon polymorphisms by a single
base extension method, which was performed
with the SNaPshot ddNTP primer extension kit
(Applied Biosystems, CA, USA). The sequences of
the forward, reverse, and extension primers used
for 46A > G were 5´-caggaaacagctatgaccgcacataac
gggcagaac-3´, 5´-tgtaaaacgacggccagtctgacacaatccac
accatc-3´, and 5´-acgtcgtggtccggcgcatggcttc-3´.
The differences in clinical characteristics among
the three groups were determined by ANOVA
and t-test analysis for continuous variables, and
by a chi-square test with multiple comparisons for
categorical variables. Differences in genotypic
frequency between the groups were tested by 
2
test using SPSS ver. 12.0 (SPSS, Chicago, IL), and
three logistic regression models (codominant,
dominant, and recessive) were used after con-
trolling for age, sex, and atopy as covariates. The
level of statistical significance was set at p 0.05.
The prevalence of atopy and total IgE are
significantly higher in patients with AIAU and
AICU than in NC (p < 0.05 for AIAU vs. NC and
AICU vs. NC, respectively), while between
AICU and AIAU, no significant differences were
noted in age, sex, atopy, serum total IgE level or
prevalence of allergic rhinitis or asthma (p > 0.05,
respectively) (Table 1). The genotype data
demonstrated that the ADRB2 polymorphism at
46 A> G showed a significant difference between
AIAU and NC; frequencies of the major allele
and genotype were significantly higher in the
Table 1. Clinical Characteristics of the Three Study Groups
Parameter AICU (n = 110) AIAU (n = 114) NC (n = 498)
Age (yrs)* 35.2 ± 11.4 35.9 ± 13.4 34 ± 15.0
Sex(male/total) 52/110 (47.3%) 56/114 (49.1%) 226/498 (45.4%)
Atopy (%) 83/110 (75.5%) 71/103 (68.9%) 46/319 (14.4%)
Serum total IgE (IU/mL) 290.3 ± 327.8 267.6 ± 297.3 103.9 ± 176.6
Bronchial asthma (%) 8/110 (7.3%) 10/104 (8.8%) 0/498 (0%)
Rhinosinusitis (%) 16/26 (61.5%) 16/22 (72.7%)
AICU, aspirin intolerant chronic urticaria; AIAU, aspirin intolerant acute urticaria; NC, normal controls.
*Values presented as means ± SD.
p value < 0.01 (AICU vs. NC and AIAU vs. NC, ANOVA and t-test for continuous variables and chi-square test with multiple
comparison for categorical variables).
Table 2. The Genotype and Allelic Frequencies of ADRB2 46A> G Polymorphism
AICU
n = 110 (%)
AIAU
n = 114 (%)
NC
n = 498 (%)
p value*
AICU
Vs. AIAU
AICU
Vs. NC
AIAU
Vs. NC
ADRB2
446 A > G
AA 35 (31.8) 48 (42.1) 149 (29.9) NS NS NS
AG 53 (48.1) 47 (41.2) 232 (46.5) NS NS NS
GG 22 (20.0) 19 (16.6) 111 (22.2) NS NS 0.017
q 0.441 0.373 0.461 NS NS 0.018
AICU, aspirin intolerant chronic urticaria; AIAU, aspirin intolerant acute urticaria; NC, normal controls, q, minor allele
frequency.
*Each p value was calculated with co-dominant, dominant and recessive models. Differences in genotypic frequency between
the groups were tested by 
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AIAU group (p = 0.017 in recessive model), while
no differences were noted in allele and genotype
frequencies between AICU and AIAU (Table 2).
Within the AIAU group, there were no signi-
ficant differences in other clinical parameters
between the two genotype groups (p > 0.05,
respectively).
In this study, we demonstrated that the ADRB2
46 A > G polymorphism was significantly asso-
ciated with the phenotype of AIAU.
2 adrenergic receptors on mast cells could be β
involved in IgE mediated mediator release from
skin mast cells.
9,10 Desensitization in the inhibition
of histamine release has been observed with the
use of 2 agonists. β
11 The ADRB2 polymorphism
in the 2-adrenergic receptor influences β the degree
of desensitization : mutants (Gly16) are more
resistant to desensitization than the wild type
(Arg16).
12 Under the same receptor desensitization
condition, attenuation of histamine release inhibi-
tion was more potent than that of PGD2 and
leukotriene. In this study, the frequencies of the
major alleles and genotypes at ADRB2 46 A > G
were significantly higher in AIAU than in NC,
suggesting that patients with the major
homozygous genotype may be more resistant to
the inhibitory effects of 2-agonists on mast cell β
degranulation. Therefore, we concluded that the
2-adrenergic receptors on mast cells of subjects β
with the major genotype at ADRB2 46 A > G are
more susceptible to histamine release from skin
mast cells when they are exposed to aspirin.
Further studies would be helpful to investigate
how this association is present in the AIAU
phenotype, but absent in the AICU phenotype.
This study suggests that the genetic poly-
morphism of the beta 2-adrenergic receptor at 46
A > G may affect the ability of mast cells to release
histamine, which could contribute to the develop-
ment of the AIAU phenotype in the Korean
population.
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